These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2165104)

  • 1. In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus).
    Meignier B; Martin B; Whitley RJ; Roizman B
    J Infect Dis; 1990 Aug; 162(2):313-21. PubMed ID: 2165104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically engineered attenuated herpes simplex viruses.
    Meignier B
    Rev Infect Dis; 1991; 13 Suppl 11():S895-7. PubMed ID: 1780614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents.
    Meignier B; Longnecker R; Roizman B
    J Infect Dis; 1988 Sep; 158(3):602-14. PubMed ID: 2842408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The owl monkey (Aotus trivirgatus) as an animal model for viral diseases and oncologic studies.
    Barahona H; Melendez LV; Hunt RD; Daniel MD
    Lab Anim Sci; 1976 Dec; 26(6 Pt 2):1104-12. PubMed ID: 190472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of experimental animals with reconstituted glycoprotein mixtures of herpes simplex virus 1 and 2: protection against challenge with virulent virus.
    Meignier B; Jourdier TM; Norrild B; Pereira L; Roizman B
    J Infect Dis; 1987 May; 155(5):921-30. PubMed ID: 3031174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic engineering and properties of novel herpes simplex viruses for use as potential vaccines and as vectors of foreign genes.
    Meignier B; Roizman B
    Adv Exp Med Biol; 1989; 257():187-92. PubMed ID: 2559609
    [No Abstract]   [Full Text] [Related]  

  • 7. The pathogenesis of acute, latent and recurrent herpes simplex virus infections.
    Klein RJ
    Arch Virol; 1982; 72(3):143-68. PubMed ID: 6180702
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation.
    Openshaw H; Asher LV; Wohlenberg C; Sekizawa T; Notkins AL
    J Gen Virol; 1979 Jul; 44(1):205-15. PubMed ID: 227991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D.
    Wachsman M; Aurelian L; Smith CC; Lipinskas BR; Perkus ME; Paoletti E
    J Infect Dis; 1987 Jun; 155(6):1188-97. PubMed ID: 3033094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intertypic superinfection of herpes simplex virus in vivo leads to reisolation of latent viruses with newly acquired lymphotropic properties.
    Darai G; Scholz J; Kurz W; Koch HG
    Dev Biol Stand; 1982; 52():67-80. PubMed ID: 6299861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease.
    Hill TJ; Field HJ; Blyth WA
    J Gen Virol; 1975 Sep; 28(3):341-53. PubMed ID: 170376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus infection in sensory ganglia: immune control, latency, and reactivation.
    Openshaw H; Puga A; Notkins AL
    Fed Proc; 1979 Dec; 38(13):2660-4. PubMed ID: 228982
    [No Abstract]   [Full Text] [Related]  

  • 13. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
    Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically engineered herpes simplex virus vaccines.
    Watson RJ; Enquist LW
    Prog Med Virol; 1985; 31():84-108. PubMed ID: 2982176
    [No Abstract]   [Full Text] [Related]  

  • 15. Herpes simplex virus latency in immunosuppressed mice.
    Rotula A; Di Luca D; Gerna G; Manservigi R; Tognon M; Cassai E
    Microbiologica; 1984 Jul; 7(3):219-27. PubMed ID: 6094985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models.
    Whitley RJ; Kern ER; Chatterjee S; Chou J; Roizman B
    J Clin Invest; 1993 Jun; 91(6):2837-43. PubMed ID: 8390490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental infection of the New World owl monkey (Aotus trivirgatus) with hepatitis A virus.
    LeDuc JW; Lemon SM; Keenan CM; Graham RR; Marchwicki RH; Binn LN
    Infect Immun; 1983 May; 40(2):766-72. PubMed ID: 6840861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal progression of viral replication and gross and histological lesions in Balb/c mice inoculated epidermally with Saimiriine herpesvirus 1 (SaHV-1).
    Breshears MA; Eberle R; Ritchey JW
    J Comp Pathol; 2005; 133(2-3):103-13. PubMed ID: 15964589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis.
    Efstathiou S; Kemp S; Darby G; Minson AC
    J Gen Virol; 1989 Apr; 70 ( Pt 4)():869-79. PubMed ID: 2543763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates.
    Hunter WD; Martuza RL; Feigenbaum F; Todo T; Mineta T; Yazaki T; Toda M; Newsome JT; Platenberg RC; Manz HJ; Rabkin SD
    J Virol; 1999 Aug; 73(8):6319-26. PubMed ID: 10400723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.